18 Aug 2008 15:02:00.000
Researchers from The University of Nottingham's Children's Brain Tumour Research Centre have demonstrated their international reputation at a major conference.
The Nottingham researchers recently attended the International Symposium on Pediatric Neuro-Oncology in Chicago, where they were selected to give 14 presentations on their work, more than any other institution.
The research was funded by the Samantha Dickson Brain Tumour Trust, which teamed up with The University of Nottingham two years ago and has made a major investment in research at the centre.
Click here for full story
The Nottingham team, led by Professor Richard Grundy and Professor David Walker, is making major progress in several areas. For example, it is one of the few centres in the world investigating a type of tumour called SPNET (supratentorial primitive neuroectodermal tumours). In a recent project funded by the Samantha Dickson Brain Tumour Trust, the researchers compared this type of tumour with another type (called a medulloblastoma), and found important genetic differences between them. This has enormous implications for treatment and diagnosis of this tumour and progress made will lead to improved treatments and increased survivability.
Professor Richard Grundy said: “I am pleased that the Children’s Brain Tumour Research Centre is receiving the recognition it deserves from an international audience at this major conference. I am grateful for the support we have received from the Samantha Dickson Brain Tumour Trust, and hope that we can continue to work together to beat brain cancer.”
Brain cancer has the highest fatality rate of all childhood cancers and affects 450 children in the UK each year. Research into the disease receives a fraction of the funding of higher profile cancers, but the Samantha Dickson Brain Tumour Trust is working hard to rectify this. The trust is the biggest brain tumour charity in the UK, and spends around £1 million per year on much-needed research in the area.
Neil Dickson, Chairman of the Samantha Dickson Brain Tumour Trust, added: “When we first started the charity, childhood brain tumour research in the United Kingdom was almost non-existent. Thanks to the first class research undertaken by the dedicated team at The University of Nottingham, the UK is now the second most active research centre in the world for childhood brain tumours after the United States. It’s something we should all be very proud of.”
— Ends —
Notes to editors:
The University of Nottingham is ranked in the UK's Top 10 and the World's Top 70 universities by the Shanghai Jiao Tong (SJTU) and Times Higher (THE) World University Rankings.
It provides innovative and top quality teaching, undertakes world-changing research, and attracts talented staff and students from 150 nations. Described by The Times as Britain's "only truly global university", it has invested continuously in award-winning campuses in the United Kingdom, China and Malaysia. Twice since 2003 its research and teaching academics have won Nobel Prizes. The University has won the Queen's Award for Enterprise in both 2006 (International Trade) and 2007 (Innovation — School of Pharmacy).
Its students are much in demand from 'blue-chip' employers. Winners of Students in Free Enterprise for four years in succession, and current holder of UK Graduate of the Year, they are accomplished artists, scientists, engineers, entrepreneurs, innovators and fundraisers. Nottingham graduates consistently excel in business, the media, the arts and sport. Undergraduate and postgraduate degree completion rates are amongst the highest in the United Kingdom.
The Samantha Dickson Brain Tumour Trust exists to find a cure for childhood and adult brain tumours through funding research and to offer support, hope and information to patients and their carers.
Founded in 1996, the trust has become the largest brain tumour charity in the UK with the highest level of laboratory-based brain tumour research in the country. The trust offers support to patients diagnosed with a brain tumour as well as their families and/or carers.